Skip Navigation



Rheumatology Advance Access published online on October 5, 2004

Rheumatology, doi:10.1093/rheumatology/keh414
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/1/40    most recent
keh414v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chang, X.
Right arrow Articles by Yamamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, X.
Right arrow Articles by Yamamoto, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received July 19, 2004
Accepted August 27, 2004

Original Papers

Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis

X. Chang 1, R. Yamada 1*, A. Suzuki 1, T. Sawada 2, S. Yoshino 3, S. Tokuhiro 1, and K. Yamamoto 4

1 Laboratory for Rheumatic Diseases, SNP Research Center, Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan
2 Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Japan
3 Department of Joint Disease and Rheumatism, Nippon Medical School, Tokyo, Japan
4 Laboratory for Rheumatic Diseases, SNP Research Center, Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan; Department of Allergy and Rheumatology, Graduate School of Medicine, University of Tokyo, Japan

* To whom correspondence should be addressed. E-mail: ryamada{at}src.riken.go.jp.


   Abstract

Objectives. Peptidylarginine deiminases (PADIs) convert peptidylarginine into citrulline via post-translational modification. Anti-citrullinated peptide antibodies are highly specific for rheumatoid arthritis (RA). Our genome-wide case-control study of single-nucleotide polymorphisms found that the PADI4 gene polymorphism is closely associated with RA. Here, we localized the expression of PADI4 and the citrullinated protein product in synovial RA tissue.

Methods. We used immunohistochemistry, double immunofluorescent labelling and western blotting.

Results. We found that PADI4 is extensively expressed in T cells, B cells, macrophages, neutrophils, fibroblast-like cells and endothelial cells in the lining and sublining areas of the RA synovium. We also found extracellular and intracellular expression of PADI4 in fibrin deposits with loose tissue structures where apoptosis was widespread. Unlike PADI4, citrullinated protein generally appeared in fibrin deposits that were abundant in the RA synovium. The citrullinated fibrin aggregate was immunoreactive against immunoglobulin (Ig) A and IgM, but not IgG and IgE. Although a little PADI4 was expressed in osteoarthritic and normal synovial tissues, significant citrullination was undetectable.

Conclusions. The results showed that PADI4 is mainly distributed in cells of various haematopoietic lineages and expressed at high levels in the inflamed RA synovium. The co-localization of PADI4, citrullinated protein and apoptotic cells in fibrin deposits suggests that PADI4 is responsible for fibrin citrullination and is involved in apoptosis. The immunoreactivity of citrullinated fibrin with IgA and IgM in the RA synovium supports the notion that citrullinated fibrin is a potential antigen of RA autoimmunity.

Keywords: Rheumatoid arthritis; Peptidylarginine deiminase 4 (PADI4); Citrullination; Fibrin; Synovial tissue.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
haematolHome page
T. Loos, G. Opdenakker, J. Van Damme, and P. Proost
Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation
Haematologica, October 1, 2009; 94(10): 1346 - 1353.
[Abstract] [Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
F. GANDJBAKHCH, I. FAJARDY, B. FERRE, S. DUBUCQUOI, R.-M. FLIPO, N. ROGER, and E. SOLAU-GERVAIS
A Functional Haplotype of PADI4 Gene in Rheumatoid Arthritis: Positive Correlation in a French Population
J Rheumatol, May 1, 2009; 36(5): 881 - 886.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. H. Shmerling
Testing for Anti-Cyclic Citrullinated Peptide Antibodies: Is It Time to Set This Genie Free?
Arch Intern Med, January 12, 2009; 169(1): 9 - 14.
[Full Text] [PDF]


Home page
BloodHome page
T. Loos, A. Mortier, M. Gouwy, I. Ronsse, W. Put, J.-P. Lenaerts, J. Van Damme, and P. Proost
Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation
Blood, October 1, 2008; 112(7): 2648 - 2656.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Tilleman, K. Van Steendam, T. Cantaert, F. De Keyser, D. Elewaut, and D. Deforce
Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides
Rheumatology, May 1, 2008; 47(5): 597 - 604.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
X. Chang, R. Yamada, A. Suzuki, Y. Kochi, T. Sawada, and K. Yamamoto
Citrullination of fibronectin in rheumatoid arthritis synovial tissue
Rheumatology, November 1, 2005; 44(11): 1374 - 1382.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.